Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did.Read how

Asia stocks climb on vaccine, U.S. stimulus optimism

Published 16/12/2020, 01:07 pm
© Reuters.

* MSCI ex-Japan jumps after 2 days of losses, Nikkei rises

* S&P 500 futures slip

* U.S. dollar pauses after Tuesday's slide

* Federal Reserve policy announcement due

* Asia stock markets this year: https://tmsnrt.rs/2zpUAr4

By Swati Pandey

SYDNEY, Dec 16 (Reuters) - Asian stocks rose on Wednesday as hopes of effective coronavirus vaccines and the growing prospect of more U.S. fiscal stimulus cheered investors ahead of the Christmas holiday season.

MSCI's broadest index of Asia Pacific shares outside of Japan .MIAPJ0000PUS added 0.6% after two straight days of losses.

The index, hovering near record highs, is up 3.3% so far in December and is on track for its best yearly performance since 2017 thanks to generous government and central bank stimulus around the world.

Australian and New Zealand shares .AXJO .NZ50 jumped over 1% each while South Korea's KOSPI .KS11 and Japan's Nikkei .N225 were each up about 0.3%.

Chinese shares started firm with the blue-chip CSI 300 index .CSI300 adding 0.25%. Hong Kong's Hang Seng index .HSI climbed 0.8%.

"We expect many emerging market economies to continue to show positive momentum in 2021 led by Asia," TD Securities wrote in a note, adding that, on aggregate, they would recover lost output from 2020.

"China is likely to see a more rapid convergence to pre-COVID GDP levels."

E-mini futures for the S&P 500 ESc1 were a tad weaker in early Asian trading, off 0.1%.

Overnight, U.S. and European stocks, gold, oil and U.S. Treasury yields were buoyant. The Dow .DJI rose 1.1% while the S&P 500 .SPX and the Nasdaq .IXIC climbed 1.3% each. .N

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Economically sensitive U.S. stock sectors, including consumer discretionary .SPLRCD and materials .SPLRCM , led gains as investors viewed a recent spike in coronavirus infections and deaths, and a grim November jobs report, as drivers of a likely COVID-19 relief and stimulus bill.

Optimism over a $1.4 trillion U.S. spending package increased after House of Representatives Speaker Nancy Pelosi invited other top congressional leaders to meet late on Tuesday to hammer out a deal to be enacted this week. on the roll-out of vaccines continued after Moderna Inc's COVID-19 vaccine appeared set for regulatory authorization this week. U.S. also expanded its roll-out of the newly approved vaccine developed by Pfizer Inc. (NYSE:PFE) PFE.N and BioNTech SE BNTX.O . will now look to the U.S. Federal Reserve for new projections on whether the economy will suffer a double-dip recession or is on the cusp of a vaccine-inspired boom.

The central bank is to release a statement later in the day, with analysts expecting some guidance on when and how the Fed might change its bond purchases. is significant chance, especially if (the) bond market becomes temporarily unruly, that the Fed will adopt Yield Curve Control (YCC) pegging three-year maturities to about 0.3% in 2021," John Vail, chief global strategist for Nikko Asset Management wrote in a note.

"The ECB is also shifting to a YCC regime, with flexible QE purchases conducted to informally maintain the yield curve to its liking, hopefully avoiding a forced massive injection of new funds."

Optimism for a trade deal on Brexit also boosted stocks, while contributing to a weaker dollar against the British pound and the euro. dollar JPY= was last at 103.67 against the Japanese yen, hovering near a recent 1-1/2 month trough. It is down 4.5% this year so far.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Against the euro EUR= , the greenback was flat at $1.2147 after two straight days of losses while it was down 0.2% at $1.3434 on sterling GBP= .

In commodities, gold prices XAU= eased a bit to $1,851.7 an ounce. GOL/

Gold, regarded as a hedge against inflation and currency debasement, has risen over 22% so far this year amid unprecedented government stimulus globally.

Brent crude LCOc1 and U.S. West Texas Intermediate crude CLc1 slipped 9 cents each to $50.67 and $47.54 a barrel respectively. Global assets

http://tmsnrt.rs/2jvdmXl Global currencies vs. dollar

http://tmsnrt.rs/2egbfVh Emerging markets

http://tmsnrt.rs/2ihRugV MSCI All Country Wolrd Index Market Cap

http://tmsnrt.rs/2EmTD6j Asia stock markets:

https://tmsnrt.rs/2zpUAr4

^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^>

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.